Evidence map›Paper›PMID 26908104›Full record

ArticleThe Journal of clinical endocrinology and metabolism2016

Bone and Mineral Metabolism: Where Are We, Where Are We Going, and How Will We Get There?

Henry M Kronenberg

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Henry M KronenbergEndocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114.
Harvard University · US

Funding

Tissue Phenotyping CoreP01DK011794 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI MANNSTADT, MICHAEL · 1986 to 2023
$44.4M
NIDDK NIH HHS DK011794NIDDK NIH HHS P01 DK011794
6 · The paper itself

Abstract

contextAdvances in diagnosing and treating metabolic bone diseases will require ways to assess cellular signaling within human bones, ideally noninvasively. Only then will we be able to fully harness the increased molecular understanding of bone that derives from human genetics and model organisms, primarily rodents. New hormones regulating mineral ion homeostasis surely remain to be discovered, probably through advances in the study of human genetic disease.

Indexed as

Bone and BonesFibroblast Growth Factor-23Fibroblast Growth FactorsHumansMineralsOsteoporosisParathyroid HormoneFibroblast Growth Factor-23Fibroblast Growth FactorsMineralsParathyroid Hormone

Identifiers

PMID26908104
PMCPMC4803156
OpenAlexW2276812592

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.